Journals / Cerrahpaşa Tıp Dergisi / 2002 / Cilt: 33 - Sayı: 3

Investigation of lecithine: Cholesterol acyltransferase and cholesterol ester transfer protein activities in coronary artery disease

Koroner arter hastalığında lesitin: Kolesterol açiltransferaz ve kolesterol ester transfer protein aktivitelerinin araştırılması

Pages
171–178
Publication Date
2022-10-10
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion.- Decreased HDL-C levels might be in connection with decreased LCAT activity and enhanced CETP activity; and as a result it might be concluded that impaired reverse cholesterol transport may be responsible for the development of coronary artery disease.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background and Design.- High density lipoprotein (HDL), lecithine: Cholesterol acyltransferase (LCAT) and cholesterol ester transfer protein (CETP) are three important factors that play role in the reverse cholesterol transport.
📊
Key Findings & Data:The subjects angiographically examined (total n= 96) were divided into four groups: those who had >50% luminal stenosis in single (n=20), double (n= 20) and triple (n= 23) coronary arteries and those who had normal (n= 33) coronary arteries.
💡
Conclusion & Impact:Conclusion.- Decreased HDL-C levels might be in connection with decreased LCAT activity and enhanced CETP activity; and as a result it might be concluded that impaired reverse cholesterol transport may be responsible for the development of coronary artery disease.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Background and Design.- High density lipoprotein (HDL), lecithine: Cholesterol acyltransferase (LCAT) and cholesterol ester transfer protein (CETP) are three important factors that play role in the reverse cholesterol transport. Disturbances related to these factors have been proposed to be responsible for the development of coronary artery disease. The subjects angiographically examined (total n= 96) were divided into four groups: those who had >50% luminal stenosis in single (n=20), double (n= 20) and triple (n= 23) coronary arteries and those who had normal (n= 33) coronary arteries. Results.- LCAT and CETP activities and total cholesterol, HDL-C, HDL2-C, low density lipoprotein-cholesterol, lipoprotein (a), apolipoprotein (apo)-AI and apo B levels had been found significantly different between subjects with coronary artery disease and those with normal coronary arteries. In patients with coronary artery disease, there were significant positive correlation between HDL-C and LCAT activity and significant negative correlation between HDL-C and CETP activity. In addition, HDL-C, HDL2-C levels and LCAT activity were significantly decreased and CETP activity was significantly increased as the severity of coronary stenosis increased. Conclusion.- Decreased HDL-C levels might be in connection with decreased LCAT activity and enhanced CETP activity; and as a result it might be concluded that impaired reverse cholesterol transport may be responsible for the development of coronary artery disease.

Özet

Ters kolesterol taşınımında rol oynayan üç önemli faktör; yüksek dansiteli lipoprotein (high density lipoprotein, HDL), lesitin: Koles¬terol açiltransferaz (lecithine: Cholesterol acyl-transferase, LCAT) ve kolesterol ester transfer protein (cholesterol ester transfer protein, CETP)'dir. Bu faktörlerle ilgili çeşitli bozuk¬luklar koroner arter hastalığı gelişiminden so¬rumlu tutulmaktadır. Çalışmaya alman, koro¬ner anjiyografileri yapılmış 96 olgudan 20'si tek damar, 20'si iki damar, 23'ü üç damar lez-yonuna sahipti. 33 olgu da ise herhangi bir lez-yon saptanmadı. LCAT ve CETP aktivitesi ile total kolesterol, HDL-K, HDL2-K, LDL-K, li¬poprotein (a), apolipoprotein Al ve B düzey¬lerinde kontrol grubu ile koroner arter hastaları arasında anlamlı farklılıklar bulundu. Koroner arter hastalarında HDL-K ile LCAT aktivitesi arasında anlamlı pozitif korelasyon, HDL-K ile CETP aktivitesi arasında da anlamlı negatif korelasyon olduğu saptandı. Ayrıca, koroner stenozdaki artışla birlikte HDL-K ve HDL2-K düzeylerinin ve LCAT enzim aktivitesinin anlamlı olarak azaldığı, CETP aktivitesinin ise anlamlı olarak arttığı gözlendi. Bu çalışmada, koroner arter hastalarında HDL-K düzeylerini düşük, LCAT enzim akti-vitesini azalmış ve CETP aktivitesini artmış olarak bulmamızın yanısıra, koroner damarlar¬da saptadığımız stenozun LCAT ve CETP akti-viteleriyle anlamlı korelasyon göstermesi de bozulan ters kolesterol taşınımmm koroner ar¬ter hastalığı gelişiminden sorumlu olabileceği görüşünü destekler nitelikte bulundu

🔖

Cite This Article

DİRİCAN, M., SARANDÖL, E., YEŞİLBURSA, D., SERDAR, A., SERDAR, Z. (2022). Investigation of lecithine: Cholesterol acyltransferase and cholesterol ester transfer protein activities in coronary artery disease. Cerrahpaşa Tıp Dergisi, Cilt: 33 - Sayı: 3, 171–178. https://ajindex.com/articles/473531

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Kwiterovich PO. The metabolic pathways of high-density lipoprotein, low-density lipoprotein, and triglycerides: A current review. Am J Cardiol 2000; 86(suppl): 5L-10L
  2. Hibino T, Sakuma N, Sato T. Higher level of plasma cholesteryl ester transfer activity from high-density lipoprotein to apo B-containing lipoproteins in subjects with angiographically detectable coronary artery disease. Clin Cardiol 1996; 19: 483-486
  3. Saku K, Zhang B, Ohta T, Arakawa K. Quantity and function of high density lipoprotein as an indicator of coronary atherosclerosis. J AM Coll Cardiol 1999; 33: 436-443
  4. Maron DJ. The epidemiology of low levels of high- density lipoprotein cholesterol in patients with and without coronary artery disease. Am J Cardiol 2000; 21: 11-14
  5. Korhonen T, Savolainen MJ, Koistinen MJ, Ikaheimo M, Linnaluoto MK, Kervinen K, Kesaniemi YA. Association of lipoprotein cholesterol and triglycerides with the severity of coronary artery disease in men and women. Atherosclerosis 1996; 127: 213-220
  6. Hill SA, McQueen MJ. Reverse cholesterol transport-A review of the process and its clinical implications. Clin Biochem 1997; 30: 517-525
  7. Kwiterovich PO. The antiatherogenic role of high-density lipoprotein cholesterol. Am J Cardiol 1998; 82: 13Q- 21Q
  8. Yamashita S, Hirano K, Sakai N, Matsuzawa Y. Molecular biology and pathophysiological aspects of ^plasma cholesteryl ester transfer protein. Biochim Biophys Acta2000; 1529: 257-275
  9. Tall AR. Plasma cholesteryl ester transfer protein and high-density lipoproteins: new insights from molecular genetic studies. J Intern Med 1995; 237: 5-12
  10. Föger B, Chase M, Amar MJ, Vaisman BL, Shamburek RD, Paigen B, Fruchart-Najib J, Paiz JA, Koch CA, Hoyt RF, Brewer HB, Santamarina-Fojo S. Cholesteryl ester transfer protein corrects dysfunctional high density lipoproteins and reduces aortic atherosclerosis in lecithin cholesterol acyltransferase transgenic mice. JHBIOI Chem 1999; 274: 36912-36920
  11. Yamashita S, Maruyama T, Hirano KI, Sakai N, Nakajima N, Matsuzawa Y. Molecular mechanisms, lipoprotein abnormalities and atherogenicity of hyperalphalipoproteinemia. Atherosclerosis 2000; 152: 271-285
  12. Yamashita S, Sakai N, Hirano K, Arai T, Ishigami M, Maruyama T, Matsuzawa Y. Molecular genetics of plasma cholesteryl ester transfer protein. Curr Opin Lipidol 1997; 8: 101-110
  13. Jonas A. Lecithin cholesterol acyltransferase. Biochim Biophys Açta 2000; 1529: 245-256
  14. Santamarina-Fojo S, Lambert G, Hoeg